Company
Lantheus Holdings, Inc. (LNTH)
Standardized SEC financial data for Lantheus Holdings, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001521036 · NASDAQ · In Vitro & In Vivo Diagnostic Substances.
Gross margin
61.1%
Operating margin
20.2%
Net margin
15.2%
Revenue growth (YoY)
0.5%
Return on equity
21.4%
ROIC
17.8%
Free cash flow
$354.1M
Debt / equity
0.52×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $339.4M | $425.2M | $935.1M | $1.30B | $1.53B | $1.54B |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $82.7M | $100.7M | $417.2M | $715.3M | $914.5M | $360.8M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $16.4M | $53.9M | $281.8M | $305.3M | $544.8M | $390.1M |
| Capital expenditures |
Get LNTH data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/LNTH/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/LNTH/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"